AU2361399A - Apparatus and method for non-invasively monitoring a patient's blood pressure - Google Patents

Apparatus and method for non-invasively monitoring a patient's blood pressure Download PDF

Info

Publication number
AU2361399A
AU2361399A AU23613/99A AU2361399A AU2361399A AU 2361399 A AU2361399 A AU 2361399A AU 23613/99 A AU23613/99 A AU 23613/99A AU 2361399 A AU2361399 A AU 2361399A AU 2361399 A AU2361399 A AU 2361399A
Authority
AU
Australia
Prior art keywords
pressure
signal
subject
fluid
blood vessel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU23613/99A
Other versions
AU737399C (en
AU737399B2 (en
Inventor
Alvis J. Somerville
Gregory I. Voss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tensys Medical Inc
Original Assignee
Tensys Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU57023/98A external-priority patent/AU5702398A/en
Application filed by Tensys Medical Inc filed Critical Tensys Medical Inc
Priority to AU23613/99A priority Critical patent/AU737399C/en
Publication of AU2361399A publication Critical patent/AU2361399A/en
Application granted granted Critical
Publication of AU737399B2 publication Critical patent/AU737399B2/en
Assigned to TENSYS MEDICAL, INC. reassignment TENSYS MEDICAL, INC. Amend patent request/document other than specification (104) Assignors: VITALWAVE CORPORATION
Publication of AU737399C publication Critical patent/AU737399C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Landscapes

  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Description

AUSTRALIA
Patents Act 1990 VITALWAVE CORPORATION
ORIGINAL
COMPLETE SPECIFICATION STANDARD PATENT Invention Title: Apparatus and method for non-invasively monitoring a patient's blood pressure The following statement is a full description of this invention including the best method of performing it known to us:- BACKGROUN1 OF THE INVENTION This invention relates generally to apparatus and methods for monitoring a subject's arterial blood pressure and, more particularly, to such apparatus and methods that monitor arterial blood pressure non-invasively by applying a pressure sensor against tissue overlying an arterial blood vessel, to partially applanate or compress the vessel.
Two well known techniques have been used to noninvasively monitor a subject's arterial blood pressure waveform, namely, auscultation and oscillometry. Both techniques use a standard inflatable arm cuff that occludes the subject's brachial artery. The auscultatory technique determines the subject's systolic and diastolic pressures by monitoring certain Korotkoff sounds that occur as the cuff is slowly deflated. The oscillometric technique, on the other hand, determines these pressures, as well as the subject's mean pressure, by measuring actual pressure changes that occur in the cuff as the cuff is deflated. Both techniques determine pressure values only intermittently, because of the need to alternately inflate and deflate the cuff, and they cannot replicate the subject's actual blood pressure waveform. Thus, true continuous, beat-to-beat blood pressure monitoring cannot be achieved using these techniques.
Occlusive cuff instruments of the kind described briefly above generally have been effective in sensing longterm trends in a subject's blood pressure. However, such instruments generally have been ineffective in sensing short- 1(
I
term blood pressure variations, which are of critical importance in many medical applications, including surgery.
One technique that has been used to provide information about short-term blood pressure variations is called arterial tonometry. One device for implementing this technique includes a rigid array of miniature pressure transducers that is applied against the tissue overlying a peripheral artery, the radial artery. The transducers each directly sense the mechanical forces in the underlying subject tissue, and each is sized to cover only a fraction of the underlying artery. The array is urged against the tissue, to applanate the underlying artery and thereby cause beat-to-beat pressure variations within the artery to be coupled through the tissue to the transducers.
The rigid arterial tonometer described briefly above is subject to several drawbacks. First, its discrete transducers are relatively expensive and, because they are exposed, they are easily damaged. In addition, the array of discrete transducers generally is not anatomically compatible with the continuous contours of the subject's tissue overlying the artery being sensed. This has led to inaccuracies in the resulting transducer signals. In addition, in some cases, this incompatibility can cause tissue injury and nerve damage and can restrict blood flow to distal tissue. Another drawback is that such rigid arterial tonometers have failed to correct for signal artifacts that arise when the subject's arm is moved. This is a particular problem when the subject is exercising or otherwise ambulating.
Yet another drawback to the arterial tonometer described briefly above is its inability to continuously monitor and adjust the level of arterial wall compression to an optimum level of zero transmural pressure. Generally, optimization of arterial wall compression has been achieved only by periodic recalibration. This has required an interruption of the patient monitoring function, which sometimes can occur during critical periods. This drawback is perhaps the most severe factor limiting acceptance of tonometers in the clinical environment.
Another device functioning similarly to the arterial tonometer includes a housing having a closed, liquid-filled chamber with one wall of the chamber defined by a flexible diaphragm. The device is applied against a subject's skin, with the flexible diaphragm pressed against the tissue overlying a peripheral artery, the radial artery, and several electrodes located in separate compartments of the chamber sense volume changes in the compartments that result from the beat-to-beat pressure variations in the underlying artery. Although the device seeks to replicate the arterial pressure waveform, it is considered to have a relatively low gain, making it unduly susceptible to noise. Further, the device must be calibrated periodically, during which time its continuous monitoring of the subject's blood pressure waveform necessarily is interrupted.
It should, therefore, be appreciated that there is a continuing need for an apparatus, and related method, for non-invasively and continuously monitoring a subject's blood pressure, with reduced susceptibility to noise and without the need to intermittently interrupt the device's normal operation for calibration. The present invention fulfills this need.
SUMMARY OF THE INVENTION The present invention resides in an improved apparatus, and related method, for non-invasively monitoring a subject's arterial blood pressure, with reduced susceptibility to noise and without the need to intermittently interrupt the pressure monitoring for calibration. The apparatus includes a pressure sensor assembly that produces a pressure signal indicative of the pressure applied against it and further includes a coupling device that urges the pressure sensor assembly into compressive engagement with tissue overlying the subject's blood vessel, to compress the vessel and ensure that pressure variations within the vessel are coupled through the tissue to the assembly. A controller controllably modulates the position of the pressure sensor assembly relative to the subject's blood vessel and monitors the resulting effect on the pressure signal, to produce a control signal that controllably positions the pressure assembly relative to the subject's blood vessel such that the vessel is compressed by a prescribed mean amount. This optimizes the coupling between the blood vessel and the sensor assembly. The pressure sensor assembly thereby senses the subject's blood pressure in an optimal manner.
More particularly, in one form of the invention, the pressure sensor assembly includes a base having an open cavity, with a flexible diaphragm extending across the cavity to define a closed, fluid-filled chamber. The controller is a fluid volume controller configured to controllably supply a fluid to and from the closed chamber, to vary the position of the flexible diaphragm relative to the tissue overlying the subject's blood vessel. By monitoring the resulting effect on the pressure signal, the controller can supply an amount of fluid to the chamber such that the subject's blood vessel is compressed by the prescribed mean amount.
In a separate and independent feature of the invention, the fluid volume controller is configured to controllably supply fluid to and from the closed chamber so as to substantially balance the variable force applied to the diaphragm by any pressure variations in the patient's blood vessel. This enables the vessel to assume an optimal geometry continuously, even during short term pressure variations due, for example, to a heartbeat pulse. This enables the masking effect of the tissue overlying the vessel to be effectively eliminated, and it enables a substantially increased gain and noise immunity to be provided.
An optimal vessel geometry is provided when the vessel's mean transmural pressure is substantially zero.
This optimal vessel geometry is achieved by configuring the fluid volume controller to modulate the fluid volume within the closed chamber while monitoring the resulting effect on the pressure signal, to produce a control signal that then is used to regulate the fluid volume such that the diaphragm is maintained at the optimal position.
More particularly, the fluid volume controller includes a vessel geometry sensor that produces a vessel geometry signal indicative of the actual geometry of the subject's blood vessel, an error signal generator that generates an error signal indicative of any difference between the actual geometry of the blood vessel and a prescribed geometry of the vessel, and a summer, responsive to the vessel geometry signal and the error signal, that produces the control signal. A fluid supply supplies the fluid to and from the closed chamber based on this control signal.
The error signal generator can include a diaphragm position sensor, in which case the vessel geometry signal is indicative of the actual position of the flexible diaphragm relative to the base. The diaphragm position sensor can include a signal generator that generates a modulation signal coupled to the summer, for incorporation into the control signal. This modulation signal causes the fluid volume controller to supply the fluid to and from the closed chamber in a manner that modulates the actual position of the flexible diaphragm about a mean position. A correlator correlates the modulation signal with the pressure signal, to sense any deviation of the diaphragm's actual mean position from a prescribed mean position and to produce the error signal.
In a more detailed feature of the invention, which can be implemented whether or not the pressure sensor assembly is coupled by a fluid to the subject's blood vessel, the modulation signal includes a succession of alternating positive and negative lobes of substantially uniform amplitude, a sine wave, and it has a frequency substantially greater than the subject's expected heartbeat frequency. In addition, the correlator is configured to compare the amplitude and shape of the pressure signal during positive lobes of the modulation signal with the amplitude and shape of the pressure signal during negative lobes of the modulation signal, which is indicative of any deviation of the pressure sensor assembly's actual mean position from its prescribed mean position. The correlator is configured to compare the amplitude of the pressure signal during a first stage of the subject's heartbeat systole) with the amplitude of the pressure signal during a second stage of the heartbeat diastole), to sense any deviation of the assembly's actual mean position from its prescribed mean position.
In another separate and independent feature of the invention, a controller is configured to controllably modulate the position of the pressure sensor assembly relative to the subject's blood vessel with a periodic signal S having a frequency substantially greater than the frequency of the subject's expected heartbeat, and the controller monitors the resulting pressure signal to produce a plurality of pressure waveforms. Each such pressure waveform corresponds to a different phase of the periodic signal, which in turn corresponds to a different nominal amount of vessel compression. The controller is configured to select the particular one of the pressure waveforms that derives from a transmural pressure of substantially zero, for example by selecting the particular waveform for which the pressure signal at systole differs from the pressure signal at diastole by a maximum amount.
Other features and advantages of the present invention should become apparent from the following description of the preferred embodiments, taken in conjunction with the accompanying drawings, which illustrate, by way of example, the principles of the invention.
BRIEF DESCRIPTION OF TIE DRAWINGS FIG. 1 is a schematic cross-sectional view of a pressure sensor assembly in accordance with the invention, in its prescribed position secured to a subject's wrist, with a flexible diaphragm and liquid-filled chamber disposed adjacent to the subject's radial artery.
FIG. 2 is a block diagram of a first embodiment of a blood pressure monitoring apparatus in accordance with the invention, incorporating the pressure sensor assembly of FIG.
1.
FIG. 3 is a graph depicting the typical sigmoid relationship between the transmural pressure of a subject's radial artery and the artery's effective diameter.
Superimposed on the graph are several waveforms representing the subject's actual blood pressure over several heartbeats, along with waveforms representing the resulting changes in the artery's effective diameter for conditions of under compression, optimal compression, and over compression.
FIGS. 4A-4C are graphs depicting the sigmoid curve of FIG. 3 and showing the effects of a small volume modulation on the transmural pressure over the time period of one heartbeat, for conditions of under compression, over compression, and optimal compression, respectively.
FIGS. 5A-5C are graphs of typical pressure signal waveforms over one heartbeat that are provided by the blood pressure monitoring apparatus of FIG. 2, for conditions of under compression, over compression, and optimal compression, respectively. The waveforms incorporate pressure oscillations that result from application of a modulation of the volume in the liquid-filled chamber.
FIG. 6 is a block diagram of a second embodiment of a blood pressure monitoring apparatus in accordance with the invention, incorporating the pressure sensor assembly of FIG.
1.
FIGS. 7A-7C are graphs of typical mean transmural pressure signal waveforms over one heartbeat that are provided by the blood pressure monitoring apparatus of FIG.
6, for conditions of under compression, over compression, and optimal compression, respectively. The waveforms incorporate pressure oscillations that result from application of a modulation of the volume in the liquid-filled chamber.
FIG. 8 is a schematic diagram of a model of the subject's wrist, with the pressure sensor assembly of FIG. 1 disposed adj-acent to it. The diagram schematic representations of the wrist's radial bone, radial artery, skin, and underlying tissue.
FIG. 9 is a block diagram of a third embodiment of a blood pressure monitoring apparatus in accordance with the invention, which incorporates the pressure sensor assembly of FIG. 1 and provides an accurate depiction of a subject's arterial pressure waveform within as little as a single heartbeat.
FIG. 10A is a graph of an exemplary pressure signal produced by the blood pressure monitoring apparatus of FIG.
9, incorporating both a sinusoidal modulation component and a subject heartbeat component.
FIG. 10B is a graph of ten reconstructed pressure waveforms reconstructed from the exemplary pressure signal of FIG. 10A by the blood pressure monitoring apparatus of FIG.
9.
DESCRIPTION OF THE PREFERRED
EMBODIMENTS
With reference now to the drawings, and particularly to FIGS. 1 and 2, there is shown a blood pressure monitoring apparatus having a sensor assembly 11 configured for attachment to a subject's wrist 13, with a flexible diaphragm 15 of the assembly compressively engaging the skin 17 and other tissue 19 overlying the subject's radial artery 21. Blood pressure variations within the artery are coupled through the tissue to the diaphragm, and through a liquid-filled chamber 23 located behind the diaphragm, to a pressure sensor 25, to produce a pressure signal output on line 27 that represents the artery's pressure waveform.
More particularly, the sensor assembly 11 includes a plastic base 29 having the shape of an inverted, shallow cup, and a wrist strap 31 that holds the base in its prescribed position on the subject's wrist 13. The flexible diaphragm 15 extends across the opening of the cup-shaped base, to define the chamber 23 that carries a suitable working liquid, water. When the sensor assembly is properly secured to the subject's wrist, it compressively engages the skin 17 and adjacent tissue 19 and compresses the radial artery 21. The amount of compression affects the degree of coupling of the pressure variations within the artery to the liquid-filled chamber 23 and, in turn, to the pressure sensor 25. The pressure sensor is coupled to the liquid-filled chamber via a low-compliance conduit 33.
FIG. 3 is a graph depicting the sigmoidal relationship between the radial artery's transmural pressure and the artery's volume, or effective diameter. Transmural pressure is the pressure across the artery wall, the pressure inside the artery minus the pressure outside the artery. A high transmural pressure indicates that the artery 21 is compressed by a small amount and thus has a relatively large effective diameter, whereas a low transmural pressure indicates that the artery is compressed by a large amount, has a flattened, oval shape and thus has a relatively small effective diameter.
It will be noted in FIG. 3 that a normal arterial pressure variation of about 50 mmHg 50 millimeters of mercury), due to a normal heartbeat, will cause-the artery's transmural pressure to vary by 50 mmHg, as well. This assumes, of course, that the pressure outside the artery 21 remains unchanged.
When the artery 21 is compressed by only a small amount, when the mean transmural pressure is highly positive, this 50 mmHg pressure excursion will cause only a relatively small change in the artery's effective diameter.
This relationship is shown by the vertically oriented waveform identified by the reference letter A in FIG. 3 and the horizontally oriented waveform identified by the reference letter B. Similarly, when the artery is compressed by a large amount, when the mean transmural pressure is highly negative, this 50 mmHg pressure excursion likewise will cause only a relatively small change in the artery's effective diameter. This relationship is shown by the vertically oriented waveform identified by the reference letter C and the horizontally oriented waveform identified by the reference letter D.
However, if the artery 21 is compressed by an amount that corresponds to a mean transmural pressure near zero, this 50 mmHg pressure excursion will cause a relatively large change in the artery's effective diameter. This relationship, which is shown by the waveforms identified by the reference letters E and F in FIG. 3, represents a maximum coupling between the arterial pressure and the sensor assembly 11. When the artery has this geometry, the arterial wall is unable to carry stress loads. It is desirable, therefore, to regulate the mean arterial compression to match this optimum value.
To this end, the apparatus further includes a volume controller 35 having a liquid source 37 that supplies liquid to and from the chamber 23 of the sensor assembly 11, via a conduit 39. The volume controller implements a control i scheme that regulates the volume of liquid within the chamber so as to provide optimal compression of the subject's radial artery 21. Under this control scheme, the volume controller actively varies the position of the sensor assembly's flexible diaphragm 15, so as to modulate, or dither, the effective diameter of the subject's artery 21, and it analyzes the resulting effect on the pressure signal produced by the pressure sensor 25. Different effects on the pressure signal are provided according to the amount of artery compression.
The volume controller 35 effects this modulation of the diaphragm's position by applying a 25-Hz sinusoidal signal to the liquid source 37. This sinusoidal signal is produced by an oscillator 41 and coupled via line 43 to a summer 45 and, in turn, via line 47 to the liquid source.
A
frequency is selected, because it is generally higher than the highest frequency components of interest in the artery's blood pressure waveform.
It will be appreciated that, if the artery 21 is under compressed, then the ac pressure response to the volume oscillation will be larger during systole than during diastole. This is because an incremental arterial volume change an incremental vertical movement along the sigmoid curve of FIG. 3) will induce a greater pressure change horizontal movement along the curve of FIG. 3) when the pressure is highest, at systole, than when the pressure is lowest, at diastole. This phenomenon is depicted in FIG. 4A, and also in FIG. 5A, which shows the pressure signal on line 27 aligned with the pressure waveform representing one heartbeat, including both a systolic stage and a diastolic stage. It will be noted that the pressure signal's ac amplitude is substantially greater during the systolic stage than during the diastolic stage.
Conversely, if the artery 21 is over compressed, then the ac amplitude of the 2 5-Hz pressure oscillation will be larger during diastole than during systole. This is because an incremental change in the effective diameter of the artery an incremental vertical movement along the curve of FIG. 3) will induce a greater pressure change horizontal movement along the curve of FIG. 3) when the pressure is lowest, at diastole, than when the pressure is highest, at systole. This phenomenon is depicted in FIG. 4B, and also in FIG. 5B, which shows the pressure signal on line 27 aligned with the pressure waveform representing one heartbeat. It will be noted that the pressure signal's ac amplitude is substantially greater during the diastolic stage than during the systolic stage.
However, if the artery 21 is optimally compressed, then the ac amplitudes of the 25-Hz pressure oscillation during the systolic and end-diastolic stages will be substantially the same4 In addition, the overall amplitude of the pressure oscillation is at a minimum when the artery is optimally compressed. This is because the sigmoid curve of FIG. 3 is steepest at the point of optimal compression.
These phenomena are depicted in FIG. 4C, and also in FIG which shows the pressure signal on line 27 aligned with the pressure waveform representing one heartbeat.
The control system for implementing the control scheme described above is depicted in FIG. 2. In addition to the volume controller 35, the sensor assembly 11, and the pressure sensor 25 identified above, the control system further includes a 25-Hz bandpass filter 49 that filters the pressure signal received on line 27 from the pressure sensor.
The filtered signal, which incorporates only the component of the pressure signal, is supplied on line 51 to the volume controller. An analyzer 53 that is part of the volume controller receives the filtered signal and compares its ac amplitude during systole with its ac amplitude during diastole, to determine whether the artery 21 is under compressed, over compressed, or optimally compressed. The analyzer produces a corresponding error signal that is supplied on line 55 to the summer 45, which sums the error signal with the 25-Hz modulation signal, to produce a control signal that controls the liquid source 37.
Operation of the control system automatically regulates the amount of liquid in the liquid-filled chamber 23 of the sensor assembly 11 such that the assembly optimally compress the subject's radial artery 21. For example, if the analyzer 53 of the volume controller 35 determines that the ac amplitude of the filtered pressure signal is greater during systole than it is during diastole, then a positive error signal is produced, which is coupled through the summer to the liquid source 37, to supply additional liquid to the sensor chamber and thereby increase the compression of the artery. The opposite would occur if the analyzer determines that the filtered pressure signal's ac amplitude is greater during diastole than it is during systole.
To provide a visible display of the subject's arterial pressure waveform, the apparatus further includes a band stop filter 57 and a display 59. The filter receives the pressure signal on line 27 from the pressure sensor 25, and it samples this signal at a rate of 50 samples per second. This sampling is phased with the modulation signal output on line 43 by the oscillator 41 such that it always occurs at the modulation signal's zero crossings. The sampled pressure signal then is coupled on line 61 to the display, for real-time display. -The use of a low-compliance liquid within the sensor chamber 23 in contrast with a relatively high-compliance gaseous fluid, provides improved coupling between the artery 21 and the pressure sensor In an alternative embodiment of the invention, not depicted in the drawings, modulation of a pressure sensor assembly relative to the subject's radial artery is achieved not by fluid volume modulation, but rather by a lever that is connected via an eccentric to a dc motor. Rotation of the motor at a frequency of, say, 25 Hz causes the sensor assembly to move toward and away from the patient's artery correspondingly.
In an independent feature of the invention, enhanced coupling of the pressure variance within the subject's radial artery 21 due to heartbeats is provided by actively maintaining the artery fixed at its optimal compression level throughout each heartbeat pulse. This is accomplished by a second, faster control system, which servo controls, in real time, the amount of liquid in the chamber 23 of the sensor assembly 11 so as to counteract the effect of the arterial pressure variations. Moreover, this servo control is effected in combination with the first, slower control system, which regulates the sensor assembly to provide the optimal mean artery compression, as described above. A block diagram of a blood pressure monitoring apparatus that implements both such control systems is provided in FIG. 6. Major portions of this apparatus are identical to the apparatus of FIG. 2 and are identified by the same reference numerals.
With reference to FIG. 6, an optical position sensor 63 incorporating a light-emitting diode and a photodiode) is carried on the base 29 of the sensor assembly 11, to provide a signal that indicates the position of the flexible diaphragm 15 relative to the base. The diaphragm position can be assumed to be related directly to the position of the subject's skin and, thus, to the effective diameter of the subject's radial artery 21. The position signal is coupled via line 65 from the position sensor directly to the summer 45 of the volume controller 35, for incorporation into the control signal supplied on line 47 to the liquid source 37.
Thus, for example, as the pressure within the artery 21 rises during systole, the position sensor 63 senses an increase in the artery's effective diameter and the position signal therefore exhibits a corresponding increase.
This increase is coupled to the liquid source 37, which responds by supplying sufficient additional liquid through the conduit 39 to the chamber 23 of the sensor assembly 11 to counteract the increased pressure. The result is that the artery's effective diameter remains substantially fixed throughout the arterial pulse. A loop bandwidth of about 100 Hz is preferred, which is significantly higher than the modulation signal and the important harmonics of the arterial pulse.
As the liquid source 37 of the volume controller regulates the volume of liquid within the chamber 23 of the sensor assembly 11 st as to maintain the effective diameter of the subject's radial artery 21 substantially fixed, the pressure within the chamber necessarily will vary. This pressure variance within the chamber will closely match the pressure waveform of the artery.
Moreover, this close match between arterial pressure and chamber pressure will occur even if a gas were to be substituted for the liquid within the chamber 23. This is because the fast servo control system provides for a virtual low compliance, even though the fluid itself might have a relatively high compliance. In some applications, the use ofa gas air) within the chamber is preferred, to simplify certain aspects of the control system's design.
When a gas is used, a greater volume will need to be transported to and from the chamber; however, the servo control system can readily accomplish this.
FIGS. 7A-7C depict the pressure signal output on line 27 by the pressure sensor 25 for the time period of one complete arterial pulse, for conditions of under compression, over compression, and optimal compression, respectively. it will be noted that the signals closely follow the actual arterial pressure waveform, which also is shown in the three drawings. It will be noted that a pressure oscillation due to the 25-Hz modulation signal is present in each of the depicted pressure signals.
In the under compression condition (FIG. 7A), the component of the pressure signal is skewed with its positive lobes significantly smaller than its negative lobes.
Conversely, in the over compression condition (FIG. 7B), the 25-Hz component of the pressure signal is skewed with its negative lobes significantly smaller than its positive lobes.
In the optimal compression condition (FIG. 7C), the component has positive and negative lobes of substantially the same amplitude. In addition, the total ac amplitude of the 25-Hz component of the pressure signal is smaller than it is when either under compressed or over compressed. This, of course, naturally follows from the shape of the sigmoid curve of FIG. 3; the incremental pressure will vary the least in response to an incremental artery diameter change at the point where the curve is steepest, where the artery's transmural pressure is zero.
The blood pressure monitoring apparatus of FIG. 6 implements a different technique from that of the apparatus of FIG. 2 to maintain the artery 21 at its optimum amount of compression. In the FIG. 6 apparatus, the analyzer 53 of the volume controller 35 examines the relative amplitudes of the positive and negative lobes of the 25-Hz component of the pressure signal, which is provided to the analyzer on line from the 25-Hz bandpass filter 49. If the negative lobes are determined to be larger than the positive lobes, then it is deduced that the artery is under compressed and an appropriate error signal is coupled to the summer 45 and, in turn, the liquid source 37. Conversely, an error signal having the opposite sense is produced if the positive lobes are determined to be larger than the negative lobes, in which case it is deduced that the artery is over compressed.
As mentioned above, the pressure signal produced by the pressure sensor 25 closely follows the actual arterial pressure waveform. This benefit is due primarily to the servo control of the flexible diaphragm 15 of the sensor assembly 11 such that the effective diameter of the artery 21 remains substantially fixed throughout each arterial pulse, as well as to the effective low compliance of the liquid within the chamber 23. The schematic diagram of FIG. 8 will help to provide an understanding of this phenomenon.
The schematic diagram of FIG. 8 includes a simple, one-dimensional spring model of the subject's wrist 13, including its radial artery 21, radial bone 67, and skin 17, as well as the tissue 19 located above and adjacent to the radial artery. Also included in the schematic diagram is a simple, one-dimensional spring model of the sensor assembly 11, including its wrist strap 31. The radial bone advantageously serves as a fairly rigid backing for the radial artery, but the artery wall and the tissue above and adjacent to the radial artery are modeled as a plurality of resilient springs. The coupling between the wrist strap and the base 29 of the sensor assembly also is modeled as a spring.
It will be appreciated that if the flexible diaphragm 15 is servo controlled so as to minimize any variation in the effective diameter of the artery 21, then the attenuating effects of the various springs that represent the wall of the artery, the skin 17, and adjacent wrist tissue 19 is effectively eliminated. The only remaining element having an attenuating effect is the spring 69 that models the coupling between the base 29 of the sensor assembly 11 and the wrist strap 31. This dramatically improves the coupling of the arterial waveform to the pressure sensor 25, whereby a substantially improved pressure signal can be produced.
In another independent feature of the invention, an accurate depiction of the subject's blood pressure waveform, and an accurate measurement of arterial pulse pressure amplitude, can be produced within as little as a single heartbeat using a monitoring apparatus as depicted in FIG. 9, which implements a special control and monitoring algorithm.
Some elements of thevapparatus of FIG. 9 correspond to elements of the apparatus of FIG. 2, and these elements are identified by the same reference numerals, but with an added prime symbol. Although the FIG. 9 apparatus is depicted as an open-loop system, it alternatively-could be implemented as a closed-loop system incorporating additional elements corresponding to those of the apparatus of FIG. 2 and/or FIG.
6.
More particularly, and with reference to FIG. 9, a liquid source 37' is connected via a conduit 39' to a chamber defined in a pressure sensor assembly 11'. The sensor assembly includes a plastic base 29, and a flexible diaphragm that cooperate to form the chamber, and this assembly is configured to be held in compressive engagement with a subject's wrist 13' by a wrist strap 31'. Actually, because the pressure waveform ordinarily can be produced within merely a few seconds, the wrist strap can be eliminated and the apparatus operated simply by pressing the diaphragm manually against the subject's wrist.
A clock circuit 71 supplies a 25-Hz sine wave signal on line 43' to the liquid source 37', to cause to liquid to be supplied to, and drawn from, the chamber of the pressure sensor assembly 11' in a sinusoidal fashion. If the assembly is being urged against the subject's wrist 13' such that the arterial wall is partially compressed, this volume modulation ordinarily will cause a corresponding sinusoidal' pressure variation about a mean pressure within the chamber.
This pressure variation is detected by a pressure sensor which is connected to the chamber via a conduit 33', to produce an analog pressure signal output on line 27' One representative waveform for the analog pressure signal on line 27' is depicted in FIG. 10A, which corresponds to a situation in which the pressure sensor assembly 11' is being urged against the subject's wrist 13' with a mean pressure of about 80 mmHg. It will be noted that the pressure signal includes not only a 25-Hz modulation component, but also a heartbeat component. The apparatus of FIG. 9 functions effectively to demodulate this waveform and thereby to produce an accurate representation of the subject's actual blood pressure waveform.
The apparatus of FIG. 9 achieves this demodulation by sampling the analog pressure signal on line 27' at a sample rate that is an integral multiple'of the modulation frequency. At a sample rate of 250 Hz, for example, ten samples would be provided for each modulation cycle. Since the first sample of each successive modulation S cycle is produced while the 25-Hz modulation component is at the same level, it follows that these first samples can be associated together to produce a depiction of the subject's variable arterial pressure for that particular level. The same is true for each of ten separate sets of samples. Thus, ten separate pressure waveforms can be generated, each representing a different nominal arterial compression.
Exemplary versions of these ten separate pressure waveforms are depicted in FIG. 10B. It will be noted that the waveform having the lowest magnitude represents the pressure samples that are made when the 25-Hz modulation waveform is at its lowest value, and that the waveform having the highest magnitude represents the pressure samples that are made when the 25-Hz modulation waveform is at its highest value. The particular one of the ten waveforms that provides the greatest difference between the systolic and diastolic values is deemed to be produced when the subject's artery is compressed by the particular amount that provides optimal coupling to the pressure sensor assembly 11'. In the exemplary case depicted in FIG. 10B, this particular waveform is depicted by the bold reference line G.
It will be appreciated that the particular one of the ten waveforms that is considered optimal will vary depending on the nominal pressure applied by the pressure sensor assembly 11' to the subject's wrist 13'. If the nominal pressure is relatively low, then the optimal waveform will likely be one of the higher-level waveforms, which are produced when the 25-Hz modulation signal is at or near its positive peak. On the other hand, if the nominal pressure is i relatively high, then the optimal waveform will likely be one of the lower-level waveforms, which are produced when the Hz modulation signal is at or near its negative peak.
With reference again to FIG. 9, the successive samples of the analog pressure signal on line 27' are produced by a sample-and-hold circuit 73, under the control of a 250-Hz clock signal supplied on line 75 from the clock circuit 71. The resulting samples are supplied on line 77 to an analog-to-digital converter 79, which produces a succession of digital words that are coupled on lines 81 to a suitable processor 83. The processor associates together the successive samples, as discussed above, to produce the ten separate waveforms, and it ascertains the particular waveform that corresponds to the optimum level of nominal artery compression. This particular waveform is then coupled via line 85 to a display 59'.
It will be appreciated that results similar to those provided by the apparatus of FIG. 9 alternatively could be provided by substituting a tonometric sensor assembly for the depicted fluidically coupled sensor assembly. The important feature to be retained is that the position of the sensor assembly relative to the subject's artery be modulated and that the resulting pressure signal be sampled at a rate that is an integral multiple of the modulation frequency.
It should be appreciated from the foregoing description that the present invention provides an improved apparatus for monitoring a subject's blood pressure, noninvasively, in which a flexible diaphragm is compressed against tissue overlying an artery with sufficient force to compress the artery by an amount that optimally-couples pressure waveforms within the artery. In addition, the amount of liquid contained within a chamber located behind the diaphragm is servo controlled, to compensate for pressure variations due to arterial pulses. This minimizes variations in the artery's effective diameter, whereby the pressure within the liquid-filled chamber is made to closely follow the actual arterial pulse waveform.
Although the invention has been described in detail with reference only to the preferred embodiments, those skilled in the art will appreciate that various modifications can be made without departing from the invention.
Accordingly, the invention is defined only by the following claims.

Claims (48)

1. Apparatus for non-invasively monitoring the pressure within a subject's blood vessel, comprising: a pressure sensor assembly that produces a pressure signal indicative of the pressure applied against it; a coupling device configured to urge the pressure sensor assembly into compressive engagement with tissue overlying a subject's blood vessel, to compress the vessel and ensure that pressure variations within the vessel are coupled through the tissue to the pressure sensor assembly; and a controller that controllably modulates the position of the pressure sensor assembly relative to the subject's blood vessel and that monitors the resulting effect on the pressure signal, to produce a control signal that controllably positions the pressure sensor assembly relative to the subject's blood vessel such that the vessel is compressed by a prescribed mean amount.
2. Apparatus as defined in claim 1, wherein the coupling device urges the pressure sensor assembly to a position that partially compresses the blood vessel and provides a mean transmural vessel pressure of substantially zero.
3. Apparatus as defined in claim 1, wherein the pressure sensor assembly includes: a base having an open cavity; a flexible diaphragm extending across the open cavity of the base to define a closed, fluid-filled chamber; and a sensor device that senses the pressure of the fluid within the closed chamber and produces the corresponding pressure signal.
4. Apparatus as defined in claim 3, wherein the controller is a fluid volume controller configured to controllably supply a fluid to and from the closed chamber, to vary the position of the flexible diaphragm relative to the tissue overlying the subject's blood vessel, such that the blood vessel is compressed by the prescribed mean amount.
Apparatus as defined in claim 4, wherein: the fluid volume controller is configured to modulate the volume of fluid within the closed chamber and to monitor the resulting effect on the pressure signal, and the control signal produced by the fluid volume controller regulates the mean amount of fluid within the chamber.
6. Apparatus as defined in claim 5, wherein: the fluid volume controller is configured to modulate the volume of fluid within the closed chamber at a substantially uniform ac amplitude; and the fluid volume controller includes a device that compares the ac amplitude of the pressure signal during systole with the ac amplitude of the pressure signal during diastole and that produces the control signal in accordance with the comparison.
7. Apparatus as defined in claim 5, wherein: the fluid volume controller is configured to modulate the volume of fluid within the closed chamber substantially sinusoidally; and the fluid volume controller includes a device that compares the ac amplitude of the pressure signal during positive portions of the fluid volume modulation with the ac amplitude of the pressure signal during negative portions of the fluid volume modulation and that produces the control signal in accordance with the comparison.
8. Apparatus as defined in claim 4, wherein: the fluid is a liquid; and the subject's blood vessel is a peripheral artery.
9. Apparatus as defined in claim i, wherein: the subject's blood vessel is a radial artery; and the pressure sensor assembly is sized to extend only over the portion of the subject's wrist that overlies the radial artery.
Apparatus as defined in claim i, wherein the controller includes: a vessel geometry sensor that produces a vessel geometry signal indicative of the actual geometry of the subject's blood vessel; an error signal generator that generates an error signal indicative of any difference between the actual geometry of the blood vessel and a prescribed geometry of the vessel; and a summer, responsive to the vessel geometry signal and the error signal, that produces the control signal.
11. Apparatus as defined in claim 10, wherein: the pressure sensor assembly includes a base7 having an open cavity, a flexible diaphragm extending across the open cavity of the base to define a closed, fluid-filled chamber, and a sensor device that senses the pressure of the fluid within the closed chamber and produces the corresponding pressure signal; and the vessel geometry sensor is a diaphragm position sensor and the vessel geometry signal is indicative of the actual position of the flexible diaphragm relative to the base.
12. Apparatus as defined in claim 10, wherein the error signal generator includes: an oscillator that produces a modulation signal that is coupled to the summer, for incorporation into the control signal, to cause the controller to modulate the actual position of the pressure sensor assembly about a mean position; and a correlator that correlates the modulation signal with the pressure signal, to sense any deviation of the pressure sensor assembly's actual mean position from the pressure sensor assembly's prescribed mean position and to produce the error signal.
13. Apparatus as defined in claim'12, wherein: the modulation signal includes a succession of alternating positive and negative lobes; and the correlator is configured to compare the amplitude and shape of the pressure signal during positive lobes of the modulation signal with the amplitude and shape of the pressure signal during negative lobes of the modulation signal, to sense any deviation of the pressure sensor assembly's actual mean position from the pressure sensor assembly's prescribed mean position and to produce the error signal.
14. Apparatus as defined in claim 12, wherein: the modulation signal has a substantially uniform ac amplitude; and the correlator is configured to compare the ac amplitude of the pressure signal during a first stage of the subject's heartbeat with the ac amplitude of the pressure signal during a second stage of the subject's heartbeat, to sense any deviation of the pressure sensor assembly's actual mean position from the pressure sensor assembly's prescribed mean position and to produce the error signal.
Apparatus as defined in claim 12, wherein: the subject's blood vessel is an artery; and the modulation signal is a sine wave having a frequency substantially greater than the subject's expected heartbeat frequency.
16. Apparatus as defined in claim 1, and further comprising means for scaling the pressure signal based on a calibration signal.
17. Apparatus as defined in claim 1, wherein: the controller is configured to modulate the position of the pressure sensor assembly relative to the subject's blood vessel at a substantially uniform ac amplitude; and the controller includes a device that compares the ac amplitude of the pressure signal during systole with the ac amplitude of the pressure signal during diastole, to produce the control signal in accordance with the comparison.
18. Apparatus as defined in claim i, wherein: the controller is configured to modulate the position of the pressure sensor assembly relative to the subject's blood vessel substantially sinusoidally; and the control-ler includes a device that compares the ac amplitude of the pressure signal during positive portions of the vessel modulation with the ac amplitude of the pressure signal during negative portions of the vessel modulation, to produce the control signal in accordance with the comparison.
19. Apparatus for non-invasively monitoring the pressure within a subject's blood vessel, comprising: a base having an open cavity; a flexible diaphragm extending across the open cavity of the base to define a closed, fluid-filled chamber; a coupling device configured to urge the diaphragm into compressive engagement with tissue overlying a subject's blood vessel, to compress the vessel and ensure that pressure variations within the vessel are coupled through the tissue to the diaphragm; a fluid volume controller that supplies a fluid to and from the closed chamber in accordance with a modulation signal, such that the flexible diaphragm oscillates about an actual mean position; a pressure sensor that senses the pressure of the fluid within the closed chamber and produces a corresponding pressure signal; a correlator that correlates the pressure signal with the modulation signal, to sense any deviation of the flexible diaphragm's actual mean position from a prescribed mean position and to produce a corresponding error signal that is coupled to the fluid volume controller, to cause the volume controller to supply fluid to or from the closed chamber, to move the flexible diaphragm toward the prescribed mean position; and a filter that filters the pressure signal to produce a filtered pressure signal indicative of the pressure within the subject's -blood vessel.
Apparatus as defined in claim 17, wherein: the apparatus further includes a diaphragm position sensor that produces a diaphragm position signal indicative of the flexible diaphragm's actual position relative to the base; and the fluid volume controller is configured to supply the fluid to and from the closed chamber in accordance with the diaphragm position signal, such that the mean position of the portion of the flexible diaphragm overlying the subject's blood vessel remains substantially fixed despite pressure variations within the blood vessel.
21. Apparatus as defined in claim 19, wherein: the modulation signal has a substantially uniform ac amplitude; and the correlator is configured to compare the amplitude of the pressure signal during a first stage of the subject's heartbeat with the amplitude of the pressure signal during a second stage of the subject's heartbeat, to sense any deviation of the flexible diaphragm' s actual mean position from the flexible diaphragm's prescribed mean position and to produce the error signal.
22. Apparatus as defined in claim 19, wherein: the modulation signal includes a succession of alternating positive and negative lobes; and the correlator is configured to compare the amplitude and shape of the pressure signal during positive lobes of the modulation signal with the amplitude and shape of the pressure signal during negative lobes of the modulation signal, to sense any deviation of the flexible diaphragm's actual mean position from the flexible diaphragm's prescribed mean position and to produce the error signal.
23. Apparatus for non-invasively monitoring the pressure within a subject's blood vessel, comprising: a base having an open cavity; a flexible diaphragm extending across the open cavity of the base to define a fluid-filled chamber; a coupling device configured to urge the diaphragm into compressive engagement with tissue overlying a subject's blood vessel, to compress the vessel and ensure that pressure variations within the vessel are coupled through the tissue to the diaphragm; a first control system that supplies fluid to and from the fluid-filled chamber such that the portion of the flexible diaphragm overlying the subject's blood vessel has a prescribed mean position that optimally compresses the blood vessel; a second control system that supplies fluid to and from the fluid-filled chamber so as to servo control the position of the flexible diaphragm and maintain the diaphragm in its prescribed mean position despite pressure variations within the subject's blood vessel; and a pressure sensor that senses the pressure of the fluid within the fluid-filled chamber and produces a corresponding pressure signal indicative of the pressure within the subject's blood vessel.
24. Apparatus for non-invasively monitoring the pressure within a subject's blood vessel, comprising: a base having an open cavity; a flexible diaphragm extending across the open cavity of the base to define a closed, fluid-filled chamber; a coupling device configured to urge the diaphragm into compressive engagement with tissue overlying a subject's blood vessel, to compress the vessel and ensure that pressure variations within the vessel are coupled through the tissue to apply a variable force against the diaphragm; a fluid volume controller that controllably supplies fluid to and from the closed chamber, to substantially balance the variable force applied to the diaphragm by any pressure variations in the patient's blood vessel; and a sensor that senses the pressure of the fluid within the closed chamber and produces a corresponding pressure signal indicative of the pressure within the subject's blood vessel.
Apparatus as defined in claim 24, wherein: the fluid volume controller includes a fluid source that supplies fluid to and from the closed chamber in accordance with a modulation signal, such that the flexible diaphragm oscillates about an actual mean position, wherein this oscillation induces a corresponding oscillation in the pressure signal produced by the sensor, and a correlator that correlates the pressure signal with the modulation signal, to sense any deviation of the flexible diaphragm's actual mean position from a prescribed mean position and to produce a corresponding error signal that is coupled to the fluid source, to cause the fluid source to supply fluid to or from the closed chamber to move the flexible diaphragm toward the prescribed mean position; and the apparatus further includes a filter that filters the pressure signal to produce a filtered pressure signal indicative of the pressure within the subject's blood vessel.
26. Apparatus as defined in claim 25, wherein: the apparatus further includes a diaphragm position sensor that produces a diaphragm position signal indicative of the flexible diaphragm's actual position relative to the base; and the fluid source is configured to supply the fluid to and from the closed chamber in accordance with the diaphragm position signal, such that the mean position of the portion of the flexible diaphragm overlying the-subject's blood vessel remains substantially fixed despite pressure variances within the blood vessel.
27. Apparatus as defined in claim 25, wherein: the modulation signal has a substantially uniform ac amplitude; and the correlator is configured to compare the amplitude of the pressure signal during a first stage of the subject's heartbeat with the amplitude of the pressure signal during a second stage of the subject's heartbeat, to sense any deviation of the flexible diaphragm's actual mean position from the flexible diaphragm's prescribed mean position and to produce the error signal.
28. Apparatus as defined in claim 25, wherein: the modulation signal includes a succession of alternating positive and negative lobes; and the correlator is configured to compare the amplitude and shape of the pressure signal during positive lobes of the modulation signal with the amplitude and shape of the pressure signal during negative lobes of the modulation signal, to sense any deviation of the flexible diaphragm's actual mean position from the flexible diaphragm's prescribed mean position and to produce the error signal.
29. Apparatus as defined in claim 25, wherein: the subject's blood vessel is an artery; and the modulation signal is a sine wave having a frequency substantially greater than the subject's expected heartbeat frequency.
Apparatus as defined in claim 25, wherein: the fluid is a liquid; and the subject's blood vessel is a peripheral artery.
31. Apparatus as defined in claim 30, wherein: the peripheral artery is a radial artery; and the diaphragm is sized to extend only over the portion of the subject's wrist that overlies the radial artery.
32. Apparatus as defined in claim 24, wherein the fluid volume controller is configured to maintain the subject's blood vessel optimally compressed continuously, without the need for separate, periodic calibration.
33. Apparatus for non-invasively monitoring the pressure within a subject's blood vessel, comprising: a pressure sensor assembly that produces a pressure signal indicative of the pressure applied against it; a coupling device configured to urge the pressure sensor assembly into compressive engagement with tissue overlying a subject's blood vessel, to compress the vessel and ensure thatp-ressure variations within the vessel are coupled through the tissue to the pressure sensor assembly; and a controller that controllably modulates the position of the pressure sensor assembly relative to the subject's blood vessel with a periodic signal having a frequency substantially greater than the frequency of the subject's expected heartbeat, wherein the controller monitors the pressure signal to produce a plurality of pressure waveforms, each corresponding to a different phase of the periodic signal.
34. Apparatus as defined in claim 33, wherein the controller further is configured to select the particular one of the pressure waveforms that derives from a transmural pressure of substantially zero.
35. Apparatus as defined in claim 34, wherein the controller further is configured to select the particular one of the pressure waveforms that derives from a transmural pressure of substantially zero by selecting the particular waveform for which the pressure signal at systole differs from the pressure signal at diastole by a maximum amount.
36. A method for non-invasively monitoring the pressure within a subject's blood vessel, comprising: providing a pressure sensor assembly that produces a pressure signal indicative of the pressure applied against it; urging the pressure sensor assembly into compressive engagement with tissue overlying a subject's blood vessel, to compress the vessel and ensure that pressure variations within the vessel are coupled through the tissue* to the pressure sensor assembly; and controllably modulating the position of the pressure sensor assembly relative to the subject's blood vessel and monitoring the resulting effect on the pressure signal, to produce a control signal that controllably positions the pressure sensor assembly relative to the subject's blood vessel such that the vessel is compressed by a prescribed mean amount.
37. A method as defined in claim 36, wherein urging includes the pressure sensor assembly to a position that partially compresses the blood vessel and provides a mean transmural vessel pressure of substantially zero.
38. A method as defined in claim 36, wherein: the pressure sensor assembly includes a base having an open cavity, a flexible diaphragm extending across the open cavity of the base to define a closed, fluid-filled chamber, and a sensor device that senses the pressure of the fluid within the closed chamber and produces the corresponding pressure signal; and controlling includes controllably supplying fluid to and from-the closed chamber, to vary the position of the flexible diaphragm relative to the tissue overlying the subject's blood vessel, such that the blood vessel is compressed by the prescribed mean amount.
39. A method as defined in claim 38, wherein: controlling includes modulating the volume of fluid within the closed chamber and monitoring the resulting effect on the pressure signal, and the control signal regulates the mean amount of fluid within the chamber.
40. A method as defined in claim 39, wherein: controlling includes modulating the volume of fluid within the closed chamber at a substantially uniform ac amplitude; and controlling further includes comparing the ac amplitude of the pressure signal during systole with the ac amplitude of the pressure signal during diastole and producing the control signal in accordance with the comparison.
41. A method as defined in claim 39, wherein: controlling includes modulating the volume of fluid within the closed chamber substantially sinusoidally; -and controlling further includes comparing the ac amplitude of the pressure signal during positive portions of the fluid volume modulation with the ac amplitude of the pressure signal during negative portions of the-fluid volume modulation and producing the control signal in accordance with the comparison.
42. A method as defined in claim 36, wherein controlling includes: sensing vessel geometry and producing a vessel geometry signal indicative of the actual geometry of the S subject's blood vessel; generating an error signal indicative of any difference between the actual geometry of the blood vessel and a prescribed geometry of the vessel; and producing the control signal based on the vessel geometry signal and the error signal.
43. A method as defined in claim 42, wherein: the pressure sensor assembly includes a base having an open cavity, a flexible diaphragm extending across the open cavity of the base to define a closed, fluid-filled chamber, and a sensor device that senses the pressure of the fluid within the closed chamber and produces the corresponding pressure signal; and sensing vessel geometry sensor includes sensing the position of the diaphragm sensor, such that the vessel geometry signal is indicative of the actual position of the flexible diaphragm relative to the base.
44. A method as defined in claim 42, wherein generating includes: modulating the actual position of the pressure sensor assembly about a mean position, the modulation being in accordance with a modulation signal; and correlating the modulation signal with the pressure signal, to sense any deviation of the pressure sensor assembly's actual mean position from the pressure sensor assembly's prescribed mean position and to produce the error signal.
A method as defined in claim 44, wherein: the modulation signal includes a succession of alternating positive and negative lobes; and correlating includes comparing the amplitude and shape of the pressure signal during positive lobes of the modulation signal with the amplitude and shape of the pressure signal during negative lobes of the modulation signal, and sensing any deviation of the pressure sensor assembly's actual mean position from the pressure sensor assembly's prescribed mean position, to produce the error signal.
46. A method as defined in claim 44, wherein: the modulation signal has a substantially uniform ac amplitude; and correlating includes comparing the ac amplitude of the pressure signal during a first stage of the subject's heartbeat with the ac amplitude of the pressure signal during a second stage of the subject's heartbeat, and sensing any deviation of the pressure sensor assembly's actual mean position from the pressure sensor assembly's prescribed mean position, to produce the error signal.
47. A method as defined in claim 36, wherein: controlling includes modulating the position of the pressure sensor assembly relative to the subject's blood vessel at a substantially uniform ac amplitude; and controlling further includes comparing the ac amplitude of the pressure signal during systole with the ac amplitude of the pressure signal during diastole, and producing the control signal in accordance with the comparison.
48. A method as defined in claim 36, wherein: controlling includes modulating the position of the pressure sensor assembly relative to the subject's blood vessel substantially sinusoidally; and controlling further includes comparing the ac amplitude of the pressure signal during positive portions of the vessel modulation with the ac amplitude of the pressure signal during negative portions of the vessel modulation, and producing the control signal in accordance with the comparison. DATED THIS 6 DAY OF APRIL 1999 VITALWAVE CORPORATION Patent Attorneys for the Applicant:- F.B.RICE CO
AU23613/99A 1996-12-13 1999-04-06 Apparatus and method for non-invasively monitoring a patient's blood pressure Ceased AU737399C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU23613/99A AU737399C (en) 1996-12-13 1999-04-06 Apparatus and method for non-invasively monitoring a patient's blood pressure

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08766810 1996-12-13
AU57023/98A AU5702398A (en) 1996-12-13 1997-12-12 Apparatus and method for non-invasively monitoring a patient's blood pressure
US09/054,288 US5964711A (en) 1996-12-13 1998-04-02 Apparatus and method for non-invasively monitoring a subject's arterial blood pressure
AU23613/99A AU737399C (en) 1996-12-13 1999-04-06 Apparatus and method for non-invasively monitoring a patient's blood pressure

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU57023/98A Division AU5702398A (en) 1996-12-13 1997-12-12 Apparatus and method for non-invasively monitoring a patient's blood pressure

Publications (3)

Publication Number Publication Date
AU2361399A true AU2361399A (en) 1999-07-22
AU737399B2 AU737399B2 (en) 2001-08-16
AU737399C AU737399C (en) 2002-08-08

Family

ID=25631510

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23613/99A Ceased AU737399C (en) 1996-12-13 1999-04-06 Apparatus and method for non-invasively monitoring a patient's blood pressure

Country Status (1)

Country Link
AU (1) AU737399C (en)

Also Published As

Publication number Publication date
AU737399C (en) 2002-08-08
AU737399B2 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
US5848970A (en) Apparatus and method for non-invasively monitoring a subject's arterial blood pressure
US6176831B1 (en) Apparatus and method for non-invasively monitoring a subject's arterial blood pressure
US6228034B1 (en) Apparatus and method for non-invasively monitoring a subjects arterial blood pressure
US6740045B2 (en) Central blood pressure waveform estimation device and peripheral blood pressure waveform detection device
JP4410767B2 (en) Continuous non-invasive blood pressure measurement device
JP3586280B2 (en) Continuous non-invasive blood pressure monitoring system
US5094244A (en) Apparatus and process for determining systolic blood pressure, diastolic blood pressure, mean arterial blood pressure, pulse rate, pulse wave shape, respiratory pattern, and respiratory rate
US5605156A (en) Flexible diaphragm tonometer
US20070055163A1 (en) Wearable blood pressure sensor and method of calibration
JP2006521838A (en) Apparatus and method for performing noninvasive blood pressure continuous measurement
WO2000062666A1 (en) A noninvasive blood pressure measuring method and apparatus
JPH084576B2 (en) Blood pressure determination device, mean arterial pressure determination device, cardiovascular condition determination device, and cardiac pacemaker adjustment support device
US6520919B1 (en) Inferior-and-superior-limb blood-pressure-index measuring apparatus
GB2279752A (en) Blood pressure measurement
JP2003144400A (en) Automatic oscillometric device and method for measuring blood pressure
AU754596B2 (en) Apparatus and method for non-invasively monitoring a subject's arterial blood pressure
AU737399B2 (en) Apparatus and method for non-invasively monitoring a patient's blood pressure
JP2006288630A (en) Blood pressure measuring apparatus and blood pressure measuring method
JP2938237B2 (en) Atherosclerosis measuring device
GB2575945A (en) System for non-invasive blood pressure measurement
JPH1094528A (en) Pulse output estimating apparatus
US6702753B2 (en) Blood pressure measuring apparatus
WO1997012542A1 (en) Improved blood pressure monitoring cuff
JP2009285027A (en) Electronic sphygmomanometer
Dubey Non Invasive Blood Pressure Measurement Techniques: A Survey

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: TENSYS MEDICAL, INC.

Free format text: FORMER NAME: VITALWAVE CORPORATION

FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20011211

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20020228